| # | Drug | Count |
|---|---|---|
| 0 | ADALIMUMAB | 3 |
| 1 | ADALIMUMAB-AATY | 2 |
| 2 | ADALIMUMAB-ADAZ | 2 |
| 3 | ADALIMUMAB-FKJP | 2 |
| 4 | FINASTERIDE | 2 |
| 5 | CARBOPLATIN | 1 |
| 6 | CISPLATIN | 1 |
| 7 | CLOZAPINE | 1 |
| 8 | ETOPOSIDE PHOSPHATE | 1 |
| 9 | ISOTRETINOIN | 1 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | ETOPOSIDE PHOSPHATE | 1 | 0.0006 |
| 1 | ADALIMUMAB-FKJP | 2 | 0.0000 |
| 2 | ADALIMUMAB-AATY | 2 | 0.0000 |
| 3 | ADALIMUMAB-ADAZ | 2 | 0.0000 |
| 4 | FINASTERIDE | 2 | 0.0000 |
| 5 | ISOTRETINOIN | 1 | 0.0000 |
| 6 | CISPLATIN | 1 | 0.0000 |
| 7 | VEDOLIZUMAB | 1 | 0.0000 |
| 8 | LEFLUNOMIDE | 1 | 0.0000 |
| 9 | CLOZAPINE | 1 | 0.0000 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | 5-alpha Reductase Inhibitor [EPC] | 2 | 0.0000 |
| 1 | Integrin Receptor Antagonist [EPC] | 1 | 0.0000 |
| 2 | Antirheumatic Agent [EPC] | 1 | 0.0000 |
| 3 | Retinoid [EPC] | 1 | 0.0000 |
| 4 | Platinum-based Drug [EPC] | 1 | 0.0000 |
| 5 | Folate Analog Metabolic Inhibitor [EPC] | 1 | 0.0000 |
| 6 | Atypical Antipsychotic [EPC] | 1 | 0.0000 |
| 7 | Tumor Necrosis Factor Blocker [EPC] | 2 | 0.0000 |